KINAXO supports pharmaceutical companies in the development of targeted drugs and predictive biomarkers for personalized healthcare.
Exit since Feb. 2011. Purchaser: Evotec AG
Dr. Andreas Jenne
Am Klopferspitz 19a
21. Jul 2006 – 09. Feb 2011